<b>Antibody Fragments in Tumor Pretargeting. </b><b>Evaluation of Biotinylated Fab</b>‘ <b>Colocalization with Recombinant Streptavidin and </b><b>Avidin</b>

  • D. Scott Wilbur
    Department of Radiation Oncology, Department of Urology, and Center for Bioengineering, University of Washington, Seattle, Washington 98195
  • Donald K. Hamlin
    Department of Radiation Oncology, Department of Urology, and Center for Bioengineering, University of Washington, Seattle, Washington 98195
  • Robert L. Vessella
    Department of Radiation Oncology, Department of Urology, and Center for Bioengineering, University of Washington, Seattle, Washington 98195
  • James E. Stray
    Department of Radiation Oncology, Department of Urology, and Center for Bioengineering, University of Washington, Seattle, Washington 98195
  • Kent R. Buhler
    Department of Radiation Oncology, Department of Urology, and Center for Bioengineering, University of Washington, Seattle, Washington 98195
  • Patrick S. Stayton
    Department of Radiation Oncology, Department of Urology, and Center for Bioengineering, University of Washington, Seattle, Washington 98195
  • Lisa A. Klumb
    Department of Radiation Oncology, Department of Urology, and Center for Bioengineering, University of Washington, Seattle, Washington 98195
  • Pradip M. Pathare
    Department of Radiation Oncology, Department of Urology, and Center for Bioengineering, University of Washington, Seattle, Washington 98195
  • S. Ananda Weerawarna
    Department of Radiation Oncology, Department of Urology, and Center for Bioengineering, University of Washington, Seattle, Washington 98195

書誌事項

公開日
1996-01-01
DOI
  • 10.1021/bc9600628
公開者
American Chemical Society (ACS)

この論文をさがす

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ